PanGen Biotech Inc (222110) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.122x

Based on the latest financial reports, PanGen Biotech Inc (222110) has a cash flow conversion efficiency ratio of -0.122x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.66 Billion ≈ $-2.48 Million USD) by net assets (₩30.03 Billion ≈ $20.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PanGen Biotech Inc (222110) defensive interval to measure how many days the company can operate on defensive assets alone.

PanGen Biotech Inc - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how PanGen Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PanGen Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PanGen Biotech Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bever Holding NV AS:BEVER	-0.009x
Asian Pac Holdings Bhd KLSE:4057	0.018x
JSS Real Estate SOCIMI SA MC:YJSS	0.002x
Red Pine Exploration Inc V:RPX	-0.383x
Entain PLC LSE:ENT	0.148x
Emami Realty Limited NSE:EMAMIREAL	0.400x
MClean Technologies Bhd KLSE:0167	0.029x
OS Therapies Incorporated NYSE MKT:OSTX	-1.000x

Annual Cash Flow Conversion Efficiency for PanGen Biotech Inc (2014–2024)

The table below shows the annual cash flow conversion efficiency of PanGen Biotech Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see PanGen Biotech Inc market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩24.91 Billion ≈ $16.88 Million	₩2.99 Billion ≈ $2.02 Million	0.120x	+143.67%
2023-12-31	₩12.57 Billion ≈ $8.52 Million	₩-3.45 Billion ≈ $-2.34 Million	-0.275x	-35.00%
2022-12-31	₩17.22 Billion ≈ $11.67 Million	₩-3.50 Billion ≈ $-2.37 Million	-0.203x	-29.11%
2021-12-31	₩21.10 Billion ≈ $14.30 Million	₩-3.32 Billion ≈ $-2.25 Million	-0.158x	+52.17%
2020-12-31	₩14.21 Billion ≈ $9.63 Million	₩-4.68 Billion ≈ $-3.17 Million	-0.329x	-65.73%
2019-12-31	₩18.43 Billion ≈ $12.49 Million	₩-3.66 Billion ≈ $-2.48 Million	-0.199x	+4.56%
2018-12-31	₩26.94 Billion ≈ $18.26 Million	₩-5.61 Billion ≈ $-3.80 Million	-0.208x	-891.15%
2017-12-31	₩31.31 Billion ≈ $21.22 Million	₩-657.84 Million ≈ $-445.81K	-0.021x	+82.93%
2016-12-31	₩35.31 Billion ≈ $23.93 Million	₩-4.35 Billion ≈ $-2.94 Million	-0.123x	+49.74%
2015-12-31	₩6.56 Billion ≈ $4.45 Million	₩-1.61 Billion ≈ $-1.09 Million	-0.245x	-95.31%
2014-12-31	₩10.69 Billion ≈ $7.24 Million	₩-1.34 Billion ≈ $-908.12K	-0.125x	--

About PanGen Biotech Inc

KQ:222110 Korea Biotechnology

Market Cap

$42.98 Million

₩63.42 Billion KRW

Market Cap Rank

#22524 Global

#1433 in Korea

Share Price

₩4700.00

Change (1 day)

-2.39%

52-Week Range

₩4510.00 - ₩7340.00

All Time High

₩24450.00